Tevogen signs letter of intent for new in-house cell therapy manufacturing facility

Return On Information New Jersey

Jul 18, 2025

Tevogen Bio, a clinical-stage specialty immunotherapy company, said July 17 that it signed a letter of intent to lease a 17,428-square-foot facility in Warren. The facility, former…